Detalhe da pesquisa
1.
E6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.
Invest New Drugs
; 37(4): 636-645, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30264293
2.
Perspective on Intradiscal Therapies for Lumbar Discogenic Pain: State of the Science, Knowledge Gaps, and Imperatives for Clinical Adoption.
J Pain Res
; 17: 1171-1182, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38524692
3.
Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Krüppel-like transcription factors.
Arterioscler Thromb Vasc Biol
; 29(10): 1587-93, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19661484
4.
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies.
Int J Radiat Oncol Biol Phys
; 83(4): 1192-7, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22245208
5.
Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female.
J Pediatr Surg
; 45(7): 1550-3, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20638543
6.
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
J Clin Oncol
; 27(23): 3830-5, 2009 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19506160